SCHEMBL2960795

SCHEMBL2960795

C[CH]N(c1ccccc1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
HTT P42858 1/20 0.40
ALDH1A1 P00352 5/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ALOX15 P16050 1/20 0.36
RELA Q04206 1/20 0.36
L3MBTL1 Q9Y468 3/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TSHR P16473 3/20 0.34
FAAH O00519 1/20 0.34
PHGDH O43175 1/20 0.34
MGLL Q99685 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8076656 0.78 MEN1 (0.37) MEN1KMT2AHTTALDH1A1NPSR1
SCHEMBL8076654 0.78 MEN1 (0.37) MEN1KMT2AHTTALDH1A1NPSR1
SCHEMBL10706531 0.75 ALDH1A1 (0.39) MEN1KMT2AHTTALDH1A1NPSR1
SCHEMBL7053933 0.74 MEN1 (0.44) MEN1KMT2AHTTALDH1A1NPSR1
SCHEMBL5516786 0.71 ALDH1A1 (0.42) MEN1KMT2AHTTALDH1A1NPSR1
SCHEMBL304901 0.71 ALDH1A1 (0.36) MEN1KMT2AHTTALDH1A1NPSR1
SCHEMBL152112 0.71 ALDH1A1 (0.41) MEN1KMT2AHTTALDH1A1NPSR1
SCHEMBL1741922 0.71 ALDH1A1 (0.39) MEN1KMT2AHTTALDH1A1NPSR1
Benzene SCHEMBL988303 0.71 ALDH1A1 (0.41) MEN1KMT2AHTTALDH1A1NPSR1
SCHEMBL43388 0.71 ALDH1A1 (0.42) MEN1KMT2AHTTALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116203180-A Quality control method of ephedra herb medicine 石家庄以岭药业股份有限公司 2023-06-02 CN claimed
US-7276567-B2 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-10-02 US claimed
WO-2024116990-A1 FRICTION MODIFIER AND LUBRICANT COMPOSITION 三洋化成工業株式会社 2024-06-06 WO disclosed
WO-2024116991-A1 WEAR INHIBITOR AND LUBRICATING OIL COMPOSITION 三洋化成工業株式会社 2024-06-06 WO disclosed
WO-2024004763-A1 VISCOSITY INDEX IMPROVER COMPOSITION AND LUBRICATING OIL COMPOSITION 三洋化成工業株式会社 2024-01-04 WO disclosed
CN-116203180-A Quality control method of ephedra herb medicine 石家庄以岭药业股份有限公司 2023-06-02 CN disclosed
CN-116165321-A Quality control method of houttuynia cordata medicinal material 石家庄以岭药业股份有限公司 2023-05-26 CN disclosed
EP-3272842-B1 LUBRICANT COMPOSITION, AND METHOD FOR MANUFACTURING LUBRICANT COMPOSITION SANYO CHEMICAL IND LTD (JP) 2022-02-16 EP disclosed
US-10336961-B2 Viscosity index improver, lubricant composition, and method for manufacturing lubricant composition SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2019-07-02 US disclosed
US-20180245014-A1 VISCOSITY INDEX IMPROVER, LUBRICANT COMPOSITION, AND METHOD FOR MANUFACTURING LUBRICANT COMPOSITION SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2018-08-30 US disclosed
EP-3272842-A1 VISCOSITY INDEX IMPROVER, LUBRICANT COMPOSITION, AND METHOD FOR MANUFACTURING LUBRICANT COMPOSITION Sanyo Chemical Industries, Ltd. (JP) 2018-01-24 EP disclosed
US-20050239981-A1 Phosphorus bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2005-10-27 US disclosed
US-20050085642-A1 Novel bipyridine derivatives SANKIO CHEMICAL CO., LTD. 2005-04-21 US disclosed
EP-0381211-A2 Optical recording media MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1990-08-08 EP disclosed
EP-0162208-B1 NOVEL N-SUBSTITUTED 3,4-DIHYDROPYRIMIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS SUNTORY KABUSHIKI KAISHA, also known as SUNTORY LTD. (JP) 1989-11-23 EP disclosed
US-4683234-A HYPOTENSIVE AGENTS, ANTI-ANGINA SUNTORY LIMITED (JP) 1987-07-28 US disclosed
EP-0162208-A2 Novel N-substituted 3,4-dihydropyrimidine derivatives, processes for preparing them and pharmaceutical compositions SUNTORY KABUSHIKI KAISHA, also known as SUNTORY LTD. (JP) 1985-11-27 EP disclosed
US-4329363-A Substituted mercapto acid amides and their use MERCK & CO., INC. (US) 1982-05-11 US disclosed
US-4216160-A IMMUNOREGULANTS FOR CORRECTING AN INBALANCE OF IMMUNE HOMEOSTASIS MERCK & CO., INC. (US) 1980-08-05 US disclosed
EP-0001989-A1 Substituted mercapto acid amides, process for their preparation, pharmaceutical composition containing same and their use MERCK & CO. INC. (US) 1979-05-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239981-A1 Phosphorus bridged metallocene compounds for olefin polymerization PYM1, ZNF207, POLL MEN1 521/4885KMT2A 3037/4885HTT 4838/4885
US-20050085642-A1 Novel bipyridine derivatives PFAS, CBR3, Q6ZSR9 MEN1 3666/4885KMT2A 3306/4885HTT 2400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.